COVID19- clinical presentation and therapeutic considerations

Area of Science:

• Infectious Diseases
• Immunology
• Pharmacology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted significant therapeutic challenges.
• Abnormal host immune responses are a primary driver of severe COVID-19 disease.
• Understanding the distinct pathogenic mechanisms across COVID-19 stages is crucial for effective treatment.

Purpose of the Study:

• To review current and potential future therapies for COVID-19.
• To identify and discuss the challenges in developing effective therapeutic options for pandemic infections.
• To summarize data on therapeutic strategies against SARS-CoV-2.

Main Methods:

• Mini-review of existing scientific literature.
• Synthesis of data on current and emerging COVID-19 therapies.
• Analysis of pathogenic mechanisms and host response in COVID-19.

Main Results:

• Few effective therapies have been identified despite extensive research efforts.
• Therapeutic development is complicated by the diverse pathological processes in COVID-19.
• Significant challenges persist in creating broadly effective treatments for SARS-CoV-2.

Conclusions:

• Developing targeted therapies for COVID-19 requires addressing complex host-pathogen interactions.
• Future research must focus on overcoming the inherent difficulties in pandemic infection therapeutics.
• Effective treatment strategies for SARS-CoV-2 are still under active investigation and development.